Uric acid and cardiovascular risk.
作者信息
Feig Daniel I, Kang Duk-Hee, Johnson Richard J
机构信息
Baylor College of Medicine, Houston, TX 77030, USA.
出版信息
N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885.
Abstract
摘要
相似文献
1
Uric acid and cardiovascular risk.
N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885.
2
Uric acid as a cardiometabolic risk factor: to be or not to be.
Contrib Nephrol. 2011;171:62-67. doi: 10.1159/000327160. Epub 2011 May 23.
3
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Hypertension. 2003 Jun;41(6):1183-90. doi: 10.1161/01.HYP.0000069700.62727.C5. Epub 2003 Apr 21.
4
Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
J Clin Hypertens (Greenwich). 2006 Jul;8(7):510-8. doi: 10.1111/j.1524-6175.2006.04755.x.
5
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
Am J Kidney Dis. 1999 Feb;33(2):225-34. doi: 10.1016/s0272-6386(99)70295-7.
6
Uric acid: an additional component of metabolic syndrome?
J Chin Med Assoc. 2006 Mar;69(3):99-100. doi: 10.1016/S1726-4901(09)70184-4.
7
Altered uric acid levels and disease states.
J Pharmacol Exp Ther. 2008 Jan;324(1):1-7. doi: 10.1124/jpet.107.129031. Epub 2007 Sep 21.
8
The role of hyperuricemia and gout in kidney and cardiovascular disease.
Cleve Clin J Med. 2008 Jul;75 Suppl 5:S13-6. doi: 10.3949/ccjm.75.suppl_5.s13.
9
Uric acid and cardiovascular risk.
N Engl J Med. 2009 Jan 29;360(5):540; author reply 540-1.
10
Hyperuricemia, urate deposition and the association with hypertension.
Curr Med Res Opin. 2015;31 Suppl 2:15-9. doi: 10.1185/03007995.2015.1087981.
引用本文的文献
1
Upcycling battery waste into Zn-BTC metal organic framework for dual applications in electrochemical sensing of uric acid and antibacterial applications.
RSC Adv. 2025 Aug 27;15(37):30564-30575. doi: 10.1039/d5ra04903b. eCollection 2025 Aug 22.
2
The association between serum uric acid to high-density lipoprotein cholesterol ratio and heart failure: a cross‑sectional study.
BMC Cardiovasc Disord. 2025 Aug 29;25(1):641. doi: 10.1186/s12872-025-05121-9.
3
Genotype Frequency of and Its Association with Paraclinical Characteristics and rs9263726 in Gout Patients.
Diagnostics (Basel). 2025 Aug 21;15(16):2114. doi: 10.3390/diagnostics15162114.
4
Managing PFAS in Sewage Sludge: Exposure Pathways, Impacts, and Treatment Innovations.
J Xenobiot. 2025 Aug 21;15(4):135. doi: 10.3390/jox15040135.
5
Machine-learning approach to atrial fibrillation prediction among individuals without prior cardiovascular diseases.
Open Heart. 2025 Aug 22;12(2):e003451. doi: 10.1136/openhrt-2025-003451.
6
Sex-specific DNA methylation associations with circulating urate levels and BCG-induced urate changes.
Commun Med (Lond). 2025 Jul 31;5(1):321. doi: 10.1038/s43856-025-01044-w.
7
Uric Acid, Colchicine and Chronic Inflammatory Diseases: A Cardiovascular Perspective.
Metabolites. 2025 Jun 20;15(7):424. doi: 10.3390/metabo15070424.
8
Genomic insertion of ancestral uricase into human liver cells to determine metabolic consequences of pseudogenization.
Sci Rep. 2025 Jul 18;15(1):26093. doi: 10.1038/s41598-025-10551-8.
9
Molecular mechanism of drug inhibition of URAT1.
Nat Commun. 2025 Jul 16;16(1):6551. doi: 10.1038/s41467-025-61226-x.
10
Higher C-reactive protein to high-density lipoprotein cholesterol ratio is associated with hyperuricemia in diabetes and prediabetes: a cross-sectional study.
Front Endocrinol (Lausanne). 2025 Jun 27;16:1619370. doi: 10.3389/fendo.2025.1619370. eCollection 2025.
本文引用的文献
1
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
JAMA. 2008 Aug 27;300(8):924-32. doi: 10.1001/jama.300.8.924.
2
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
Nat Genet. 2008 Apr;40(4):437-42. doi: 10.1038/ng.106. Epub 2008 Mar 9.
3
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
Nat Genet. 2008 Apr;40(4):430-6. doi: 10.1038/ng.107. Epub 2008 Mar 9.
4
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.
Clin J Am Soc Nephrol. 2008 May;3(3):706-13. doi: 10.2215/CJN.04271007. Epub 2008 Feb 13.
5
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Am J Physiol Renal Physiol. 2008 Apr;294(4):F710-8. doi: 10.1152/ajprenal.00454.2007. Epub 2008 Jan 23.
6
Fructose ingestion acutely elevates blood pressure in healthy young humans.
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R730-7. doi: 10.1152/ajpregu.00680.2007. Epub 2008 Jan 16.
7
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.
J Hypertens. 2008 Feb;26(2):269-75. doi: 10.1097/HJH.0b013e3282f240bf.
8
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey.
Arthritis Rheum. 2008 Jan 15;59(1):109-16. doi: 10.1002/art.23245.
9
Plasma uric acid and the risk of type 2 diabetes in a Chinese community.
Clin Chem. 2008 Feb;54(2):310-6. doi: 10.1373/clinchem.2007.095190. Epub 2007 Dec 18.
10
High serum uric acid as a novel risk factor for type 2 diabetes.
Diabetes Care. 2008 Feb;31(2):361-2. doi: 10.2337/dc07-1276. Epub 2007 Oct 31.
Zotero 插件